BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 12716823)

  • 1. New insights on oxidative stress and diabetic complications may lead to a "causal" antioxidant therapy.
    Ceriello A
    Diabetes Care; 2003 May; 26(5):1589-96. PubMed ID: 12716823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular targets of diabetic vascular complications and potential new drugs.
    Da Ros R; Assaloni R; Ceriello A
    Curr Drug Targets; 2005 Jun; 6(4):503-9. PubMed ID: 16026269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathogenesis of diabetic complications: the role of DNA injury and poly(ADP-ribose) polymerase activation in peroxynitrite-mediated cytotoxicity.
    Kiss L; Szabó C
    Mem Inst Oswaldo Cruz; 2005 Mar; 100 Suppl 1():29-37. PubMed ID: 15962096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidant therapy in diabetic complications: what is new?
    Da Ros R; Assaloni R; Ceriello A
    Curr Vasc Pharmacol; 2004 Oct; 2(4):335-41. PubMed ID: 15320813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of gliclazide beyond metabolic control.
    Ceriello A
    Metabolism; 2006 May; 55(5 Suppl 1):S10-5. PubMed ID: 16631804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of poly(ADP-ribose) polymerase-1 activation in the pathogenesis of diabetic complications: endothelial dysfunction, as a common underlying theme.
    Pacher P; Szabó C
    Antioxid Redox Signal; 2005; 7(11-12):1568-80. PubMed ID: 16356120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The preventive anti-oxidant action of thiazolidinediones: a new therapeutic prospect in diabetes and insulin resistance.
    Da Ros R; Assaloni R; Ceriello A
    Diabet Med; 2004 Nov; 21(11):1249-52. PubMed ID: 15498094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress and diabetes-associated complications.
    Ceriello A
    Endocr Pract; 2006; 12 Suppl 1():60-2. PubMed ID: 16627383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic endothelial dysfunction: role of reactive oxygen and nitrogen species production and poly(ADP-ribose) polymerase activation.
    Soriano FG; Virág L; Szabó C
    J Mol Med (Berl); 2001 Aug; 79(8):437-48. PubMed ID: 11511974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Oxidative Stress in Diabetic Neuropathy: Generation of Free Radical Species in the Glycation Reaction and Gene Polymorphisms Encoding Antioxidant Enzymes to Genetic Susceptibility to Diabetic Neuropathy in Population of Type I Diabetic Patients.
    Babizhayev MA; Strokov IA; Nosikov VV; Savel'yeva EL; Sitnikov VF; Yegorov YE; Lankin VZ
    Cell Biochem Biophys; 2015 Apr; 71(3):1425-43. PubMed ID: 25427889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Novel antioxidant therapeutic strategies for cardiovascular dysfunction associated with ageing].
    Radovits T
    Orv Hetil; 2008 Dec; 149(50):2377-85. PubMed ID: 19073445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Postprandial hyperglycemia as a risk factor in the development of endothelial dysfunction--how to prevent?].
    Ljubić S; Boras J; Vidjak V
    Lijec Vjesn; 2008; 130(1-2):21-5. PubMed ID: 18589639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of nitrosative stress in the pathogenesis of diabetic vascular dysfunction.
    Szabo C
    Br J Pharmacol; 2009 Mar; 156(5):713-27. PubMed ID: 19210748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies.
    Pacher P; Obrosova IG; Mabley JG; Szabó C
    Curr Med Chem; 2005; 12(3):267-75. PubMed ID: 15723618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlling oxidative stress as a novel molecular approach to protecting the vascular wall in diabetes.
    Ceriello A
    Curr Opin Lipidol; 2006 Oct; 17(5):510-8. PubMed ID: 16960499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress.
    Rolo AP; Palmeira CM
    Toxicol Appl Pharmacol; 2006 Apr; 212(2):167-78. PubMed ID: 16490224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress in brain ischemia.
    Love S
    Brain Pathol; 1999 Jan; 9(1):119-31. PubMed ID: 9989455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells.
    Du X; Matsumura T; Edelstein D; Rossetti L; Zsengellér Z; Szabó C; Brownlee M
    J Clin Invest; 2003 Oct; 112(7):1049-57. PubMed ID: 14523042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice.
    Johansen JS; Harris AK; Rychly DJ; Ergul A
    Cardiovasc Diabetol; 2005 Apr; 4():5. PubMed ID: 15862133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of nitrosative stress and poly(ADP-ribose) polymerase activation in diabetic vascular dysfunction.
    Mabley JG; Soriano FG
    Curr Vasc Pharmacol; 2005 Jul; 3(3):247-52. PubMed ID: 16026321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.